Search News
| 3.09 Delayed Data As of Apr 19 |  +0.06 / +1.98%Today’s Change | 0.38 Today|||52-Week Range 4.95 | -24.08% Year-to-Date |
| Previous close | 3.03 |
| Today’s open | 3.03 |
| Day’s range | 2.98 - 3.20 |
| Volume | 667,304 |
| Average volume (3 months) | 1,483,145 |
| Market cap | $205.3M |
| Earnings growth (last year) | -119.44% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| IMMYImprimis Pharmaceuti... | +0.04 | +1.72% |
| CTRVContraVir Pharmaceut... | +0.00 | +0.19% |
| CDMOPAvid Bioservices Inc | -0.12 | -0.48% |
| PRPHProPhase Labs Inc | +0.09 | +3.13% |
| Last reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Holli Cherevka |
Corporate headquarters Englewood, Colorado |
